Bacteriology of community-acquired peritonitis in children treated in the university hospital of Marrakech;Profil bactériologique des péritonites communautaires de l'enfant prises en charge au CHU de Marrakech

Annales Francaises d'Anesthesie et de Reanimation

Volumn 32, Issue 1, 2013, Pages 60-62

  Mouaffak, Y ^a   Boutbaoucht, M ^a   Soraa, N ^a   Chabaa, L ^a   Salama, T ^a   Oulad Saiad, M ^a   Younous, S ^a  

^a CADI AYYAD UNIVERSITY   (Morocco)

Author keywords

Antibiotherapy; Pediatrics; Peritonitis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN; ERTAPENEM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PERITONITIS; BACTERIOLOGY; BACTERIUM ISOLATION; CHILD HEALTH CARE; CLINICAL ARTICLE; COMMUNITY ACQUIRED PERITONITIS; CONCENTRATION RESPONSE; DRUG EFFECT; ESCHERICHIA COLI; HUMAN; MOROCCO; NONHUMAN; PERITONEAL FLUID; TREATMENT PLANNING; UNIVERSITY HOSPITAL;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ASCITIC FLUID; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MOROCCO; PERITONITIS;

EID: 84872668193     PISSN: 07507658     EISSN: 17696623     Source Type: Journal    
DOI: 10.1016/j.annfar.2012.10.031     Document Type: Article

References (12)

1. Société française d'anesthésie-réanimation Prise en charge des péritonites communautaires-Conférence de consensus-texte court. Ann Fr Anesth Reanim 2001, 20(Suppl. 2):368s-373s.
2. Leone M., Boyadjiev I., Martin C. Péritonites communautaires : quelle antibiothérapie probabiliste. Urg Prat 2007, 80:31-34.
3. Nejmi H., Laghla B., Boutbaoucht M., Samkaoui M.A. évolution des résistances de l'Escherichia coli au cours des péritonites communautaires. Med Mal Infect 2011, 41:218-220.
4. Eddlimi A., Abouelhassan T., El Adib A.G., Oueldbaallal H., Younous S., Samkaoui M.A. Profil bactériologique des péritonites communautaires. J Magh A Rea Med Urg 2006, 8:64-66.
5. Dumont R., Cinotti R., Lejus C., Caillon J., Boutoille D., Roquilly A., et al. The microbiology of community-acquired peritonitis in children. Pediatr Infect Dis J 2011, 30:131-135.
6. Guillet-Carubaa C., Cheikhelardb A., Guilleta M., Billea E., Descampsa P., Yinb L., et al. Bacteriologic epidemiology and empirical treatment of pediatric complicated appendicitis. Diagn Microbiol Infect Dis 2011, 69:376-381.
7. Newman N., Wattad E., Greenberg D., Peled N., Cohen Z., Leibovitz E. Community6acquired complicated intra abdominal infections in children hospitalized during 1995-2004 at a paediatric surgery department. Scand J Infect Dis 2009, 41:720-726.
8. Rodríguez-Baño J., Navarro M.D. Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective. Clin Microbiol Infect 2008, 14(Suppl. 1):104-110.
9. Hawser S.P., Bouchillon S.K., Hoban D.J., Badal R.E. In vitro susceptibilities of aerobic and facultative anaerobic Gram negative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART study. Int J Antimicrob Agents 2009, 34:585-588.
10. Seguin P., Laviolle B., Chanavaz C., Donnio P.Y., Gautier-Lerestif A.L., Campion J.P., et al. Factors associated with multidrug-resistant bacteria in secondary peritonitis: impact on antibiotic therapy. Clin Microbiol Infect 2006, 12:980-985.
11. Sartelli M. A focus on intra-abdominal infections. World J Emerg Surg 2010, 5:2-20.
12. Nadler E.P., Gaines B.A. The Surgical Infection Society guidelines on antimicrobial therapy for children with appendicitis. Surg Infect (Larchmt) 2008, 9:75-83. Therapeutic Agents Committee of the Surgical Infection Society.